Index
1 Market Overview of Microbiome and Metagenomic Services
1.1 Microbiome and Metagenomic Services Market Overview
1.1.1 Microbiome and Metagenomic Services Product Scope
1.1.2 Microbiome and Metagenomic Services Market Status and Outlook
1.2 Global Microbiome and Metagenomic Services Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Microbiome and Metagenomic Services Market Size by Region (2018-2029)
1.4 Global Microbiome and Metagenomic Services Historic Market Size by Region (2018-2023)
1.5 Global Microbiome and Metagenomic Services Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Microbiome and Metagenomic Services Market Size (2018-2029)
1.6.1 North America Microbiome and Metagenomic Services Market Size (2018-2029)
1.6.2 Europe Microbiome and Metagenomic Services Market Size (2018-2029)
1.6.3 Asia-Pacific Microbiome and Metagenomic Services Market Size (2018-2029)
1.6.4 Latin America Microbiome and Metagenomic Services Market Size (2018-2029)
1.6.5 Middle East & Africa Microbiome and Metagenomic Services Market Size (2018-2029)
2 Microbiome and Metagenomic Services Market by Type
2.1 Introduction
2.1.1 Sequencing Service
2.1.2 Analysis Software Service
2.2 Global Microbiome and Metagenomic Services Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Microbiome and Metagenomic Services Historic Market Size by Type (2018-2023)
2.2.2 Global Microbiome and Metagenomic Services Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Microbiome and Metagenomic Services Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Microbiome and Metagenomic Services Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Microbiome and Metagenomic Services Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Microbiome and Metagenomic Services Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Microbiome and Metagenomic Services Revenue Breakdown by Type (2018-2029)
3 Microbiome and Metagenomic Services Market Overview by Application
3.1 Introduction
3.1.1 Medical Treatment
3.1.2 Pharmaceutical
3.1.3 Agriculture
3.1.4 Other
3.2 Global Microbiome and Metagenomic Services Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Microbiome and Metagenomic Services Historic Market Size by Application (2018-2023)
3.2.2 Global Microbiome and Metagenomic Services Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Microbiome and Metagenomic Services Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Microbiome and Metagenomic Services Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Microbiome and Metagenomic Services Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Microbiome and Metagenomic Services Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Microbiome and Metagenomic Services Revenue Breakdown by Application (2018-2029)
4 Microbiome and Metagenomic Services Competition Analysis by Players
4.1 Global Microbiome and Metagenomic Services Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Microbiome and Metagenomic Services as of 2022)
4.3 Date of Key Players Enter into Microbiome and Metagenomic Services Market
4.4 Global Top Players Microbiome and Metagenomic Services Headquarters and Area Served
4.5 Key Players Microbiome and Metagenomic Services Product Solution and Service
4.6 Competitive Status
4.6.1 Microbiome and Metagenomic Services Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 CAGEF
5.1.1 CAGEF Profile
5.1.2 CAGEF Main Business
5.1.3 CAGEF Microbiome and Metagenomic Services Products, Services and Solutions
5.1.4 CAGEF Microbiome and Metagenomic Services Revenue (US$ Million) & (2018-2023)
5.1.5 CAGEF Recent Developments
5.2 OraSure Technologies, Inc.(Diversigen)
5.2.1 OraSure Technologies, Inc.(Diversigen) Profile
5.2.2 OraSure Technologies, Inc.(Diversigen) Main Business
5.2.3 OraSure Technologies, Inc.(Diversigen) Microbiome and Metagenomic Services Products, Services and Solutions
5.2.4 OraSure Technologies, Inc.(Diversigen) Microbiome and Metagenomic Services Revenue (US$ Million) & (2018-2023)
5.2.5 OraSure Technologies, Inc.(Diversigen) Recent Developments
5.3 Zymo Research
5.3.1 Zymo Research Profile
5.3.2 Zymo Research Main Business
5.3.3 Zymo Research Microbiome and Metagenomic Services Products, Services and Solutions
5.3.4 Zymo Research Microbiome and Metagenomic Services Revenue (US$ Million) & (2018-2023)
5.3.5 Biomcare Recent Developments
5.4 Biomcare
5.4.1 Biomcare Profile
5.4.2 Biomcare Main Business
5.4.3 Biomcare Microbiome and Metagenomic Services Products, Services and Solutions
5.4.4 Biomcare Microbiome and Metagenomic Services Revenue (US$ Million) & (2018-2023)
5.4.5 Biomcare Recent Developments
5.5 CosmosID
5.5.1 CosmosID Profile
5.5.2 CosmosID Main Business
5.5.3 CosmosID Microbiome and Metagenomic Services Products, Services and Solutions
5.5.4 CosmosID Microbiome and Metagenomic Services Revenue (US$ Million) & (2018-2023)
5.5.5 CosmosID Recent Developments
5.6 Epistem Ltd.
5.6.1 Epistem Ltd. Profile
5.6.2 Epistem Ltd. Main Business
5.6.3 Epistem Ltd. Microbiome and Metagenomic Services Products, Services and Solutions
5.6.4 Epistem Ltd. Microbiome and Metagenomic Services Revenue (US$ Million) & (2018-2023)
5.6.5 Epistem Ltd. Recent Developments
5.7 Azenta
5.7.1 Azenta Profile
5.7.2 Azenta Main Business
5.7.3 Azenta Microbiome and Metagenomic Services Products, Services and Solutions
5.7.4 Azenta Microbiome and Metagenomic Services Revenue (US$ Million) & (2018-2023)
5.7.5 Azenta Recent Developments
5.8 CeGaT GmbH
5.8.1 CeGaT GmbH Profile
5.8.2 CeGaT GmbH Main Business
5.8.3 CeGaT GmbH Microbiome and Metagenomic Services Products, Services and Solutions
5.8.4 CeGaT GmbH Microbiome and Metagenomic Services Revenue (US$ Million) & (2018-2023)
5.8.5 CeGaT GmbH Recent Developments
5.9 GENEWIZ
5.9.1 GENEWIZ Profile
5.9.2 GENEWIZ Main Business
5.9.3 GENEWIZ Microbiome and Metagenomic Services Products, Services and Solutions
5.9.4 GENEWIZ Microbiome and Metagenomic Services Revenue (US$ Million) & (2018-2023)
5.9.5 GENEWIZ Recent Developments
6 North America
6.1 North America Microbiome and Metagenomic Services Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Microbiome and Metagenomic Services Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Microbiome and Metagenomic Services Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Microbiome and Metagenomic Services Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Microbiome and Metagenomic Services Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Microbiome and Metagenomic Services Market Dynamics
11.1 Microbiome and Metagenomic Services Industry Trends
11.2 Microbiome and Metagenomic Services Market Drivers
11.3 Microbiome and Metagenomic Services Market Challenges
11.4 Microbiome and Metagenomic Services Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List